Veterinary Medicines Information website

Insol Trichophyton suspension for injection

Authorised
  • Trichophyton verrucosum, strain 410, Inactivated
  • Trichophyton mentagrophytes, strain 1032, Inactivated
  • Trichophyton mentagrophytes, strain 551, Inactivated
Download as PDF

Product identification

Medicine name:
Insol Trichophyton suspension for injection
Active substance:
  • Trichophyton verrucosum, strain 410, Inactivated
  • Trichophyton mentagrophytes, strain 1032, Inactivated
  • Trichophyton mentagrophytes, strain 551, Inactivated
Target species:
  • Cattle
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Trichophyton verrucosum, strain 410, Inactivated
    17000000.00
    cells
    /
    1.00
    millilitre(s)
  • Trichophyton mentagrophytes, strain 1032, Inactivated
    17000000.00
    cells
    /
    1.00
    millilitre(s)
  • Trichophyton mentagrophytes, strain 551, Inactivated
    17000000.00
    cells
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        3
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AQ
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:
  • (ID2) 100 millilitre(s): Box with 1 Vial (Glass type II) with 100 millilitre(s), closed with Stopper (Bromobutyl Rubber) and Cap (Aluminium)
  • (ID1) 50 millilitre(s): Box with 1 Vial (Glass type II) with 50 millilitre(s), closed with Cap (Aluminium) and Stopper (Bromobutyl Rubber)
  • (ID3) 250 millilitre(s): Box with 1 Vial (Glass type II) with 250 millilitre(s), closed with Stopper (Bromobutyl Rubber) and Cap (Aluminium)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Wirtschaftsgenossenschaft deutscher Tieraerzte eG
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • 277a/94
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0201/001
Concerned member states:
  • Sweden

Documents

Combined File of all Documents

English (PDF)
Published on: 28/08/2026
Download
German (PDF)
Published on: 28/08/2026
Download